Stage I Lung Cancer AJCC v7
generalStage I includes: IA: (T1a, N0, M0); (T1b, N0, M0) and IB: (T2a, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less n greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer
32
Centers
32
Active Trials
—
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Stage IB Lung Cancer AJCC v7 | — |
Top Centers for Stage I Lung Cancer AJCC v7(32)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 51.6 |
| 2 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 51.6 |
| 3 | NCI Comprehensive Active Research Program | 51.6 |
| 4 | NCI Comprehensive Active Research Program | 51.6 |
| 5 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 51.6 |
| 6 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 51.6 |
| 7 | NCI Comprehensive Active Research Program | 51.6 |
| 8 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 51.6 |
| 9 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 51.6 |
| 10 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 51.6 |
| 11 | NCI Clinical Active Research Program | 51.6 |
| 12 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 51.6 |
| 13 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 51.6 |
| 14 | Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive Active Research Program | 51.6 |
| 15 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 51.6 |
| 16 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 51.6 |
| 17 | University of Illinois Cancer CenterChicago, IL Active Research Program | 51.6 |
| 18 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 51.6 |
| 19 | Boston University Cancer CenterBoston, MA Active Research Program | 51.6 |
| 20 | Active Research Program | 51.6 |
| 21 | Cancer Center at IllinoisUrbana, IL Active Research Program | 51.6 |
| 22 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 51.6 |
| 23 | Penn State Cancer InstituteHershey, PA Active Research Program | 51.6 |
| 24 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 51.6 |
| 25 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 51.6 |
| 26 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 51.6 |
| 27 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 51.6 |
| 28 | Ellis Fischel Cancer Center, MU Health CareColumbia, MO Active Research Program | 51.6 |
| 29 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 51.6 |
| 30 | Loma Linda University Cancer CenterLoma Linda, CA Active Research Program | 51.6 |
| 31 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 51.6 |
| 32 | Active Research Program | 51.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →